GlassScriptPhysician profile
Alan J Feldman
NPI 1114961851
$861.56
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $278 · 2021: $72.53 · 2022: $134 · 2023: $16.73 · 2024: $20.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $36.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $36.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $301.09 | 2019-2022 | |
| Abbvie INC. | $250.01 | 2019-2021 | |
| Hologic Sales and Service, LLC | $86.27 | 2019-2021 | |
| Daiichi Sankyo INC. | $44.04 | 2020-2021 | |
| Lupin INC. | $39.35 | 2019 | |
| Astellas Pharma US INC | $25.09 | 2019 | |
| Evofem Biosciences, INC. | $23.85 | 2020 | |
| Novo Nordisk INC | $20.02 | 2024 | |
| Pfizer INC. | $16.73 | 2023 | |
| Millicent US INC | $14.35 | 2020 | |
| Glaxosmithkline, LLC. | $14.31 | 2019 | |
| Merck Sharp & Dohme LLC | $13.27 | 2021 | |
| Allergan, INC. | $13.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.